The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Khan, Monsur Yazdani
    Director born in September 1961
    Individual (1 offspring)
    Officer
    2019-01-31 ~ now
    OF - director → CIF 0
    Mr Monsur Yazdani Khan
    Born in September 1961
    Individual (1 offspring)
    Person with significant control
    2018-06-26 ~ now
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
Ceased 4
  • 1
    Chudasama, Nish
    Director born in May 1969
    Individual (4 offsprings)
    Officer
    2022-02-14 ~ 2023-11-15
    OF - director → CIF 0
  • 2
    Khan, Monsur Yazdani
    Businessman born in September 1961
    Individual (1 offspring)
    Officer
    2018-06-26 ~ 2018-12-01
    OF - director → CIF 0
    Mr Monsur Yazdani Khan
    Born in September 1961
    Individual (1 offspring)
    Person with significant control
    2018-06-26 ~ 2018-12-01
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
  • 3
    Ali, Abdul Hamin
    Director born in October 1967
    Individual (4 offsprings)
    Officer
    2016-01-21 ~ 2021-02-01
    OF - director → CIF 0
    Ali, Abdul Hamin
    Individual (4 offsprings)
    Officer
    2022-01-01 ~ 2022-01-01
    OF - secretary → CIF 0
    Mr Abdul Hamin Ali
    Born in October 1967
    Individual (4 offsprings)
    Person with significant control
    2016-04-06 ~ 2018-06-26
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 4
    Esmail, Arif
    Director born in February 1963
    Individual (6 offsprings)
    Officer
    2016-01-21 ~ 2021-02-01
    OF - director → CIF 0
    Mr Arif Esmail
    Born in February 1963
    Individual (6 offsprings)
    Person with significant control
    2016-04-06 ~ 2018-06-26
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
parent relation
Company in focus

NASILA PHARMA LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Debtors
33,194 GBP2023-01-31
31,777 GBP2022-01-31
Cash at bank and in hand
306 GBP2023-01-31
58 GBP2022-01-31
Current Assets
33,500 GBP2023-01-31
31,835 GBP2022-01-31
Net Current Assets/Liabilities
-75,112 GBP2023-01-31
-64,263 GBP2022-01-31
Creditors
Non-current
-37,624 GBP2023-01-31
-43,578 GBP2022-01-31
Net Assets/Liabilities
-112,736 GBP2023-01-31
-107,841 GBP2022-01-31
Equity
Called up share capital
5 GBP2023-01-31
5 GBP2022-01-31
Retained earnings (accumulated losses)
-112,741 GBP2023-01-31
-107,846 GBP2022-01-31
Equity
-112,736 GBP2023-01-31
-107,841 GBP2022-01-31
Average Number of Employees
22022-02-01 ~ 2023-01-31
Other Debtors
Current
7,968 GBP2023-01-31
7,653 GBP2022-01-31
Debtors - Deferred Tax Asset
Current
25,226 GBP2023-01-31
24,124 GBP2022-01-31
Debtors
Current, Amounts falling due within one year
33,194 GBP2023-01-31
31,777 GBP2022-01-31
Bank Borrowings/Overdrafts
Current
6,060 GBP2023-01-31
6,062 GBP2022-01-31
Trade Creditors/Trade Payables
Current
34,643 GBP2023-01-31
35,057 GBP2022-01-31
Other Creditors
Current
67,909 GBP2023-01-31
54,979 GBP2022-01-31
Bank Borrowings/Overdrafts
Non-current
37,624 GBP2023-01-31
43,578 GBP2022-01-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
5 shares2023-01-31
Par Value of Share
Class 1 ordinary share
1 GBP2022-02-01 ~ 2023-01-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
300 shares2023-01-31
Par Value of Share
Class 2 ordinary share
1 GBP2022-02-01 ~ 2023-01-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
100 shares2023-01-31
Par Value of Share
Class 3 ordinary share
1 GBP2022-02-01 ~ 2023-01-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
50 shares2023-01-31
Par Value of Share
Class 4 ordinary share
1 GBP2022-02-01 ~ 2023-01-31
Equity
Called up share capital
5 GBP2022-01-31
  • NASILA PHARMA LIMITED
    Info
    Registered number 09963244
    Suite 2, Cedar Court Grove Business Park, White Waltham, Maidenhead, Berkshire SL6 3LW
    Private Limited Company incorporated on 2016-01-21 (9 years 5 months). The company status is Active.
    The last date of confirmation statement was made at 2024-01-20
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.